Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJ Bell Regulatory News (AJB)

Share Price Information for AJ Bell (AJB)

Share Price is delayed by 15 minutes
Get Live Data
613.50    5.00 (0.82%)
Bid:
613.00
Ask:
614.00
Spread: 1.00 (0.163%)
Market Cap: £2.42b
AJB Live PriceLast checked at - London Stock Exchange

Intraday AJ Bell Share Chart

Director/PDMR Shareholding

4 Feb 2022 16:09

RNS Number : 7938A
AJ Bell PLC
04 February 2022
 

 

AJ Bell plc

("AJ Bell", the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

AJ Bell wishes to announce that due to an administrative oversight the number of annual and deferred awards over the Company's ordinary shares of £0.000125 each (Ordinary Shares) granted to Roger Stott, the chief operating officer and a person discharging managerial responsibilities (PDMR) in the Company, under the AJ Bell Executive Incentive Plan (EIP) on 9 December 2021, which was announced on 13 December 2021, was less than should have been granted.

As a consequence of the above, on 4 February 2022 the Company granted Roger Stott an additional annual award in respect of 31,680 Ordinary Shares and an additional deferred award in respect of 47,520 Ordinary Shares. Roger Stott has now been granted an annual award in respect of a total of 44,000 Ordinary Shares and a deferred award in respect of a total of 66,000 Ordinary Shares in relation to the performance period ending on 30 September 2022.

No consideration was paid for the grant of the awards, which have been structured as nominal cost options, and: 

a) the annual award will normally vest once it has been determined if, and the extent to which, the performance conditions have been satisfied, which will ordinarily be within 75 days of the end of the performance period on 30 September 2022.

b) the deferred award will, subject to the satisfaction of the performance conditions and the operation of a performance underpin, malus and clawback, normally vest on the first day on which dealings in the Company's shares by PDMRs are permitted under the Company's share dealing code after 30 September 2025.

c) both the annual award and the deferred award will be subject to a holding period which expires on 30 September 2026, and will, ordinarily, remain exercisable until the day before the tenth anniversary of the date of grant. Clawback will continue to apply up until the end of the holding period.

 

For further information, please contact:

AJ Bell plc

Bruce Robinson, Company Secretary +44 (0) 780 234 4859

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Roger Stott

 

2.

Reason for the notification

a)

Position/status

Chief Operating Officer/PDMR

 

b)

Initial notification/ Amendment

 

This is an initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

AJ Bell plc

 

b)

LEI

213800VNKA7DPWXWJJ36

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 Ordinary shares of £0.000125 each

 

Identification code

ISIN: GB00BFZNLB60

b)

Nature of the transaction

1. Grant of an annual award under the EIP. The award is structured as a nominal cost option which will ordinarily vest once it has been determined if, and the extent to which, the performance conditions set for the award have been satisfied, which will ordinarily be within 75 days of the end of the performance period on 30 September 2022; and

 

2. Grant of a deferred award under the EIP. The award is structured as a nominal cost option which will ordinarily vest if, and the extent to which, the performance conditions set for the award have been satisfied, on the first day on which dealings in the Company's shares by PDMRs are permitted under the Company's share dealing code after 30 September 2025.

 

c)

Price(s) and volume(s)

Type of award

Price(s)

Volume(s)

Annual award

£0.000125

31,680

Deferred award

£0.000125

47,520

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable single transaction

e)

Date of the transaction

4 February 2022

f)

Place of the transaction

Outside a trading venue

 

Name of officer of issuer responsible for making notification: Bruce Robinson (Company Secretary)

Date of notification: 4 February 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGGZVDNGZZM
Date   Source Headline
12th Dec 202212:24 pmRNSIssue of ordinary shares
5th Dec 20224:05 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:39 pmRNSHolding(s) in Company
1st Dec 20228:43 amRNSBlock Listing Application
1st Dec 20227:00 amRNSFinal Results
29th Nov 20225:38 pmRNSHolding(s) in Company
29th Nov 20225:36 pmRNSHolding(s) in Company
15th Nov 20229:52 amRNSDirector/PDMR Shareholding
15th Nov 20229:39 amRNSNotice of Results
11th Nov 20225:10 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSYear-end Trading Update
13th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20222:31 pmRNSDirector/PDMR Shareholding
3rd Oct 20228:00 amRNSConsultancy Agreement
29th Sep 20224:45 pmRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSBoard Changes
14th Sep 202211:26 amRNSDirector/PDMR Shareholding
9th Sep 20228:20 amRNSDirector/PDMR Shareholding
9th Sep 20228:20 amRNSDirector/PDMR Shareholding
1st Sep 20229:00 amRNSIssue of Ordinary Shares & Total Voting Rights
1st Sep 20229:00 amRNSDirector/PDMR Shareholding
22nd Aug 20225:04 pmRNSNomination Committee changes
15th Aug 20229:01 amRNSDirector/PDMR Shareholding
12th Aug 20228:52 amRNSDirector/PDMR Shareholding
21st Jul 20227:00 amRNSQ3 Trading Update
12th Jul 20221:04 pmRNSDirector/PDMR Shareholding
30th Jun 20228:12 amRNSIssue of Ordinary Shares & Total Voting Rights
24th Jun 20227:00 amRNSBlock listing six monthly return
16th Jun 20224:42 pmRNSDirectorate Change
15th Jun 20222:22 pmRNSDirector/PDMR Shareholding
1st Jun 20229:41 amRNSDirector/PDMR Shareholding
1st Jun 20229:37 amRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSInterim Results
13th May 20221:24 pmRNSDirector/PDMR Shareholding
26th Apr 20228:52 amRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSQ2 Trading Update
20th Apr 20229:08 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:47 amRNSAdmission of Shares & Total Voting Rights
15th Mar 20222:35 pmRNSDirector/PDMR Shareholding
14th Mar 20222:36 pmRNSDirector/PDMR Shareholding
1st Mar 20224:37 pmRNSIssue of Ordinary Shares & Total Voting Rights
16th Feb 20228:58 amRNSDirector/PDMR Shareholding
14th Feb 202210:43 amRNSHolding(s) in Company
14th Feb 202210:22 amRNSDirector/PDMR Shareholding
4th Feb 20224:09 pmRNSDirector/PDMR Shareholding
27th Jan 202211:54 amRNSDirector/PDMR Shareholding
26th Jan 20224:16 pmRNSResult of AGM
21st Jan 20222:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.